about
Radiolabeling of DOTA-like conjugated peptides with generator-produced (68)Ga and using NaCl-based cationic elution method.Investigation of the pharmacokinetics of 3'-deoxy-3'-[18F]fluorothymidine uptake in the bone marrow before and early after initiation of chemoradiation therapy in head and neck cancer.Locally targeted delivery of a micron-size radiation therapy source using temperature-sensitive hydrogelPreparation of a versatile bifunctional zeolite for targeted imaging applicationsUnderstanding the Radioactive Ingrowth and Decay of Naturally Occurring Radioactive Materials in the Environment: An Analysis of Produced Fluids from the Marcellus ShaleMitochondrial-Targeted Decyl-Triphenylphosphonium Enhances 2-Deoxy-D-Glucose Mediated Oxidative Stress and Clonogenic Killing of Multiple Myeloma CellsKinetic analysis of 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) in head and neck cancer patients before and early after initiation of chemoradiation therapyRepeatability of gallium-68 DOTATOC positron emission tomographic imaging in neuroendocrine tumors.Improved synthesis and biological evaluation of chelator-modified α-MSH analogs prepared by copper-free click chemistry.Temporal characterization of flowback and produced water quality from a hydraulically fractured oil and gas well.O2⋅- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.Polonium-210 accumulates in a lake receiving coal mine discharges-anthropogenic or natural?Radiolabeling optimization and characterization of (68)Ga labeled DOTA-polyamido-amine dendrimer conjugate - Animal biodistribution and PET imaging results.A simple-rapid method to separate uranium, thorium, and protactinium for U-series age-dating of materials.Partitioning of naturally-occurring radionuclides (NORM) in Marcellus Shale produced fluids influenced by chemical matrix.Radiosynthesis of clinical doses of ⁶⁸Ga-DOTATATE (GalioMedix™) and validation of organic-matrix-based ⁶⁸Ge/⁶⁸Ga generators.A DOTA-peptide conjugate by copper-free click chemistry.Synthesis and Evaluation of Tetraarylethylene-based Mono-, Bis-, and Tris(pyridinium) Derivatives for Image-Guided Mitochondria-Specific Targeting and Cytotoxicity of Metastatic Melanoma Cells.Investigation of the tritium content in surface water, bottom sediments (zoobenthos), macrophytes, and fish in the mid-stream region of the Yenisei River (Siberia, Russia).90Y-DOTATOC Dosimetry-Based Personalized Peptide Receptor Radionuclide Therapy.Quantitation of lead-210 (210Pb) using lead-203 (203Pb) as a "Massless" yield tracer.Automated cassette-based production of high specific activity [203/212Pb]peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer.Localization of Unknown Primary Site with 68Ga-DOTATOC PET/CT in Patients with Metastatic Neuroendocrine Tumor.Monitoring radionuclides in subsurface drinking water sources near unconventional drilling operations: a pilot study.Optimizing the removal of carbon phases in soils and sediments for sequential chemical extractions by coulometryO2⋅− and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological AscorbateHigh content screening identifies monensin as an EMT-selective cytotoxic compoundModeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.An assessment of radionuclidic impurities of (210)Po produced via neutron irradiation of (209)Bi for use in targeted alpha-particle radiotherapyLiquid-scintillation-based anticoincidence counting of Co-60 and Pb-210Enrichment of excess 210Po in anoxic pondsRadionuclide calibrator measurements of (18)F in a 3ml plastic syringeA performance evaluation of 90Y dose-calibrator measurements in nuclear pharmacies and clinics in the United StatesAssessing the 210At impurity in the production of 211At for radiotherapy by 210Po analysis via isotope dilution alpha spectrometrySimplified NaCl based (68)Ga concentration and labeling procedure for rapid synthesis of (68)Ga radiopharmaceuticals in high radiochemical purityOptimizing the radiosynthesis of [68Ga]DOTA-MLN6907 peptide containing three disulfide cyclization bonds - a GCC specific chelate for clinical radiopharmaceuticalsEnhancing the Efficacy of Melanocortin 1 Receptor-Targeted Radiotherapy by Pharmacologically Upregulating the Receptor in Metastatic MelanomaCorrigendum to "Automated cassette-based production of high specific activity [203/212Pb]peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer" [Appl. Radiat. Isot. 127 (2017) 52-60]
P50
Q30314932-83CA221C-A39F-4B30-8D61-979818A82BB1Q34061931-F7890EB6-91BA-4537-8D68-F095404622A1Q34688143-C574A6FF-B4D0-44CC-9151-6AAC58FABA32Q35038168-43CE7762-03F9-4BD3-A614-BF503E32300EQ35820675-3D770D1F-1E78-4FA5-8881-B127607DF6F8Q36208283-4DB2E23F-AF5C-46D6-843B-340BE31B9F14Q37349950-BEC2E62F-107F-42AE-89B9-94419A7B0816Q37504159-4609016C-E109-474E-838E-103F23C2D534Q38382330-2D14A2B6-0C00-420C-9317-52BF63BED2DEQ38690204-BE3D6942-B058-4DDB-BD55-00D763564E88Q38709364-AF6C49B4-2A8E-40EF-8A2B-8C74C60AD98FQ39028405-BC94482F-5D39-43CC-B574-E68DF6214795Q40671172-29E6D354-0D74-4627-9649-8B6EC5EB1589Q41201879-9197D7B6-3A4B-4BF0-8BA6-C1C978CC7195Q41201888-CB519426-0D35-4132-BD5B-4E0BC734865FQ41201900-7A678BFC-495B-45DD-A057-86B21130EDC5Q42039958-5F5553AA-38D8-4F0E-92F9-AF92AB650E2AQ42326557-0C587ED0-D515-4734-BB11-A2FE975F205EQ46700099-A080DF70-88C6-48B3-9B8C-DCB64228425EQ52663694-61A4CB49-ED70-4186-9A06-7821DDFAF707Q52718556-700EFBBB-B0E3-4C76-A712-797F3363D8A4Q52838956-073087C9-F660-43C0-8D13-F9BF867AB53AQ52914636-977EE444-756B-48A7-9344-32040D8964A2Q53329052-9CD631D8-6375-410B-9339-E7B43BC58B1FQ57223968-6749EDCE-ED49-4DC4-BFDE-F4E99CC72C9BQ57598558-7C99CCAE-CDCF-4043-9547-B5B0419425EDQ61800959-B17E0247-EC95-4C8F-8F8C-25D95DC5BF49Q64907922-2AEBFB55-C7A4-4B75-AB0C-EBD1AD215F3FQ80233115-647198F5-8F29-4020-A99B-6858C43F432AQ80876876-5CF6F016-93A7-4564-9C98-17DB774BB90FQ80957175-306B174C-4973-4938-B54D-98A41B2B7301Q80978469-EB4F1966-A9DF-4AC9-9166-F9E0BFCB043CQ81434741-2319F5EB-07A8-47B9-9C4F-8F0E7F5317E4Q82966213-16A8AB21-AE9F-4B5E-82E4-1CDFCA591F7CQ84512331-362C2763-EF6A-483C-ACB6-AB1C85F53D28Q91108096-99B9F0D5-D0B6-4ADA-946E-A5E7A6982A05Q91987435-4763AA16-332F-4FD3-97C0-69BF5C02174FQ92770863-88A8AFAC-4988-43C3-90B0-495C60F1E962
P50
description
researcher ORCID ID = 0000-0002-4554-2212
@en
wetenschapper
@nl
name
Michael K Schultz
@ast
Michael K Schultz
@en
Michael K Schultz
@es
Michael K Schultz
@nl
type
label
Michael K Schultz
@ast
Michael K Schultz
@en
Michael K Schultz
@es
Michael K Schultz
@nl
prefLabel
Michael K Schultz
@ast
Michael K Schultz
@en
Michael K Schultz
@es
Michael K Schultz
@nl
P106
P1153
55943586300
P31
P496
0000-0002-4554-2212